tailieunhanh - Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

In clinical practice the gold standard method to assess BRAF status in patients with metastatic melanoma is based on molecular assays. Recently, a mutation-specific monoclonal antibody (VE1), which detects the BRAF V600E mutated protein, has been developed |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN